Top compounds associated with response to CLCN6

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	16-beta-bromoandrosterone	CTRPv2	pan-cancer	AAC	0.07	0.07
mRNA	CAL-101	CTRPv2	pan-cancer	AAC	0.068	0.07
mRNA	Docetaxel	gCSI	pan-cancer	AAC	-0.11	0.07
mRNA	Vandetanib	CTRPv2	pan-cancer	AAC	-0.068	0.07
mRNA	Cisplatin	GDSC1000	pan-cancer	AAC	-0.065	0.08
mRNA	Obatoclax Mesylate	CTRPv2	pan-cancer	AAC	0.062	0.08
mRNA	LY317615	GDSC1000	pan-cancer	AAC	-0.063	0.08
mRNA	JQ-1:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.062	0.08
mRNA	tacedinaline	CTRPv2	pan-cancer	AAC	0.069	0.08
mRNA	Doxorubicin	FIMM	pan-cancer	AAC	-0.27	0.08

Download CSV